chr12-49051149-CG-C
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_003482.4(KMT2D):c.2533delC(p.Arg845GlyfsTer85) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,359,590 control chromosomes in the GnomAD database, with no homozygous occurrence. There is a variant allele frequency bias in the population database for this variant (GnomAdExome4), which may indicate mosaicism or somatic mutations in the reference population data. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R845R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_003482.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndromeInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
- Kabuki syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KMT2D | NM_003482.4 | c.2533delC | p.Arg845GlyfsTer85 | frameshift_variant | Exon 11 of 55 | ENST00000301067.12 | NP_003473.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KMT2D | ENST00000301067.12 | c.2533delC | p.Arg845GlyfsTer85 | frameshift_variant | Exon 11 of 55 | 5 | NM_003482.4 | ENSP00000301067.7 | ||
| KMT2D | ENST00000683543.2 | c.2533delC | p.Arg845GlyfsTer85 | frameshift_variant | Exon 11 of 56 | ENSP00000506726.1 | ||||
| KMT2D | ENST00000685166.1 | c.2533delC | p.Arg845GlyfsTer85 | frameshift_variant | Exon 10 of 54 | ENSP00000509386.1 | ||||
| KMT2D | ENST00000692637.1 | c.2533delC | p.Arg845GlyfsTer85 | frameshift_variant | Exon 10 of 54 | ENSP00000509666.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.0000118 AC: 16AN: 1359590Hom.: 0 Cov.: 33 AF XY: 0.0000180 AC XY: 12AN XY: 667472 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Kabuki syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg845Glyfs*85) in the KMT2D gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with KMT2D-related disease. Loss-of-function variants in KMT2D are known to be pathogenic (PMID: 22126750). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at